유럽 연합 -
스웨덴어 -
EMA (European Medicines Agency)
senshio
shionogi b.v. - ospemifen - postmenopause - könshormoner och modulatorer av könsorganen, - senshio is indicated for the treatment of moderate to severe symptomatic vulvar and vaginal atrophy (vva) in post-menopausal women.